Sucampo to be Added to NASDAQ Biotechnology Index

Sucampo Pharmaceuticals SCMP (SPI) today announced that NASDAQ OMX Group, Inc. NDAQ will include the company in the NASDAQ Biotechnology Index® NBI effective prior to market open on Monday, May 20, 2013. The NASDAQ Biotechnology Index is designed to track the performance of a set of securities listed on The NASDAQ Stock Market that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark (ICB). The NASDAQ Biotechnology Index is a modified market capitalization weighted index. Among the various criteria that must be met in order to be eligible for inclusion in this index are a market capitalization of at least $200 million and an average daily trading See full press release
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidanceContractsManagementGlobal
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!